商品名：Lincocin, Lincoject
Inhibition of bacterial protein synthesis. It is bacteriostatic or bactericidal, depending on the organism and drug concentration. Being a weak base, it is ion-trapped in fluid that is more acidic than plasma and therefore concentrates in prostatic fluid, milk and intracellular fluid.
Active against Gram-positive cocci (including penicillin-resistant staphylococci) and many obligate anaerobes. The lincosamides (lincomycin and clindamycin) are particularly indicated for staphylococcal bone and joint infections. Clindamycin is more active than lincomycin, particularly against obligate anaerobes, and is better absorbed from the gut. Administer slowly if using i.v. route.
劑量數字暫停提供：VetPro 的劑量改依 DRUGAPI 藥物資料庫對外的內容，DRUGAPI 目前不提供可直接計算的劑量。下方列出 DRUGAPI 的審查結論與劑量審查引用的來源；計算機可手動輸入劑量換算。
人工評估前必須同時核對精確產品、有效成分組合、物種與生產類別、感染部位、病原與藥敏、產品標示適應症、濃度、給藥途徑、暴露計畫、監測、停止條件、共用藥、食用動物身分、殘留與停藥規範及適用法域；任一項缺失即維持封鎖。
DRUGAPI 劑量審查引用的獸醫官方標示（各標示只適用於其產品、物種與法域，不可互換）
依出現頻率分組；嚴重副作用獨立列出，臨床上需立即辨識。
renal